Eileen Dolan of the University of Chicago presents a talk on personalized cancer medicine. A primary aim of pharmacogenomics is to devise personalized treatment strategies based on an individual’s genetic makeup to maximize the potential for therapeutic benefit and minimize the risk of adverse side effects. Dr. Dolan will discuss the role of pharmacogenomics in cancer research, a field in which personalized drug therapy is especially desirable given the narrow therapeutic index and life-threatening consequences of drug toxicity.
A public reception will precede this event in the VTC Cafe at 5:00 p.m.
Virginia Tech Carilion School of Medicine and Research Institute 2 Riverside Circle, Roanoke, Virginia 24016 View Map
Education & Learning